SPYD vs VHT
SPDR Portfolio S&P 500 High Dividend ETF vs Vanguard Health Care ETF
- • SPYD has the lower expense ratio at 0.07% vs 0.09% for VHT.
- • SPYD pays a higher dividend yield (4.20%).
Side-by-side metrics
| Metric | SPYD | VHT |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.07% | 0.09% |
Dividend yield Trailing 12-month yield. | 4.20% | 1.35% |
AUM Assets under management — bigger funds are typically more liquid. | $7.64B | $23.73B |
YTD return | 19.42% | 22.17% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.55 | 0.46 |
P/E ratio | 15.99 | 32.41 |
Last price | $49.87 | $347.68 |
Inception | — | — |
Issuer | State Street | Vanguard |
SPYD top holdings
| ACN | Accenture PLC Class A | 2.35% |
| HAS | Hasbro Inc | 1.71% |
| PFE | Pfizer Inc | 1.57% |
| CVX | Chevron Corp | 1.56% |
| MDT | Medtronic PLC | 1.51% |
| SWK | Stanley Black & Decker Inc | 1.48% |
| EOG | EOG Resources Inc | 1.47% |
| HPQ | HP Inc | 1.46% |
| CCI | Crown Castle Inc | 1.46% |
| AMT | American Tower Corp | 1.44% |
VHT top holdings
| LLY | Eli Lilly and Co | 12.93% |
| JNJ | Johnson & Johnson | 8.78% |
| ABBV | AbbVie Inc | 6.45% |
| MRK | Merck & Co Inc | 5.01% |
| UNH | UnitedHealth Group Inc | 4.65% |
| TMO | Thermo Fisher Scientific Inc | 3.50% |
| AMGN | Amgen Inc | 3.18% |
| GILD | Gilead Sciences Inc | 2.58% |
| ABT | Abbott Laboratories | 2.40% |
| PFE | Pfizer Inc | 2.27% |
About SPYD
SPYD (SPDR Portfolio S&P 500 High Dividend ETF) is Top 80 highest-yielding S&P 500 stocks. Managed by State Street, the fund carries $7.6B in assets under management, an expense ratio of 0.07%, a dividend yield of 4.20%. Its largest holding is Accenture PLC Class A (ACN), which represents 2.4% of the portfolio. Real Estate is the fund's largest sector exposure at 24.2%.
About VHT
VHT (Vanguard Health Care ETF) is US health care sector stocks. Managed by Vanguard, the fund carries $23.7B in assets under management, an expense ratio of 0.09%, a dividend yield of 1.35%. Its largest holding is Eli Lilly and Co (LLY), which represents 12.9% of the portfolio. Technology is the fund's largest sector exposure at 0.0%.